Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease
Pleurodesis is considered to be one of the treatment options against MPE in patients with ILD. However, two cases of ARDS were observed; thus, clinicians should carefully consider the indication of pleurodesis in the patients who had the recent onset of ILD and were treated with systemic prednisolone.
Authors
- Masaru Matsumoto (ORCID: https://orcid.org/0000-0003-0246-395X)
- Akari Murata
- Takehiro Tozuka (ORCID: https://orcid.org/0000-0002-3774-8915)
- Atsuhiro Nagano
- Yukari Shirakura
- Kazuo Kasahara (ORCID: https://orcid.org/0000-0001-5551-1543)
- Hirokazu Iso (ORCID: https://orcid.org/0000-0002-3672-679X)
- Yozo Sato (ORCID: https://orcid.org/0000-0001-7605-8434)
- Koichiro Kamio (ORCID: https://orcid.org/0000-0002-6870-9548)
- Masahiro Seike (ORCID: https://orcid.org/0000-0002-1572-5472)
- Kaoruko Shinbu
- Akihiko Miyanaga (ORCID: https://orcid.org/0000-0003-2026-9181)
- Tomoyasu Inoue
- Susumu Takeuchi (ORCID: https://orcid.org/0000-0002-0617-0962)
- Katsuyuki Higa
- Kazuhito Misawa (ORCID: https://orcid.org/0000-0002-4948-2245)
Institutions
- Nippon Medical School (JP)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/jtd-24-1541
- Primary Topic
- Pleural and Pulmonary Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00